IL110018A0 - Biologically active vasopressin analogues - Google Patents

Biologically active vasopressin analogues

Info

Publication number
IL110018A0
IL110018A0 IL11001894A IL11001894A IL110018A0 IL 110018 A0 IL110018 A0 IL 110018A0 IL 11001894 A IL11001894 A IL 11001894A IL 11001894 A IL11001894 A IL 11001894A IL 110018 A0 IL110018 A0 IL 110018A0
Authority
IL
Israel
Prior art keywords
biologically active
vasopressin analogues
active vasopressin
analogues
biologically
Prior art date
Application number
IL11001894A
Other languages
English (en)
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of IL110018A0 publication Critical patent/IL110018A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/16Oxytocins; Vasopressins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/15Oxytocin or vasopressin; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IL11001894A 1993-06-18 1994-06-15 Biologically active vasopressin analogues IL110018A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9302124A SE501677C2 (sv) 1993-06-18 1993-06-18 Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel

Publications (1)

Publication Number Publication Date
IL110018A0 true IL110018A0 (en) 1994-10-07

Family

ID=20390346

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11001894A IL110018A0 (en) 1993-06-18 1994-06-15 Biologically active vasopressin analogues

Country Status (16)

Country Link
US (1) US5698516A (ja)
EP (1) EP0703924A1 (ja)
JP (1) JPH08511557A (ja)
KR (1) KR960702847A (ja)
CN (1) CN1125451A (ja)
AU (1) AU7088394A (ja)
CA (1) CA2163352A1 (ja)
CZ (1) CZ332295A3 (ja)
FI (1) FI956050A0 (ja)
HU (1) HUT73674A (ja)
IL (1) IL110018A0 (ja)
NO (1) NO955058L (ja)
PL (1) PL312202A1 (ja)
SE (1) SE501677C2 (ja)
WO (1) WO1995000548A1 (ja)
ZA (1) ZA944195B (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE501678C2 (sv) * 1993-07-13 1995-04-10 Ferring Bv Peptid med oxytocinantagonistaktivitet samt farmaceutisk komposition innehållande nämnda peptid
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
PT1530967E (pt) * 2003-11-13 2006-09-29 Ferring Bv Embalagem blister e uma forma de dosagem solida que compreende desmopressina.
SE528446C2 (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
RU2342949C1 (ru) * 2007-03-26 2009-01-10 Юрий Георгиевич Жуковский Применение [дезамино-1, изолейцин-3, аргинин-8]вазопрессина в качестве средства для увеличения выведения почкой солей натрия и усиления обратного избирательного всасывания из почечных канальцев в кровь воды-растворителя
US8399410B2 (en) 2007-08-06 2013-03-19 Allergan, Inc. Methods and devices for desmopressin drug delivery
DK3085381T3 (en) 2008-05-21 2018-05-28 Ferring Bv ORODISPERSIBLE DESMOPRESSIN TO INCREASE THE INITIAL PERIOD OF SLEEP UNDERSTANDED BY NEW TURRY
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
JO3371B1 (ar) * 2013-07-26 2019-03-13 Ferring Bv ناهضات مستقبل فاسوبريسين 2
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9375478B1 (en) 2015-01-30 2016-06-28 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
RU2634272C1 (ru) * 2016-08-10 2017-10-24 Закрытое акционерное общество "Санкт-Петербургский институт фармации" Композиция с дезамино-аргинин-вазотоцином для парентерального введения и способ её получения

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE399252B (sv) * 1976-05-24 1978-02-06 Ferring Ab Forfarande for framstellnign av antidiuretiskt verkande desamino-asparagin Ÿ4-d-argininŸ8-vasopressin
CA1246055A (en) * 1980-03-24 1988-12-06 Joseph H. Cort N-.omega.-substituted hormonogens of vasopressin and its synthetic analogs
US4491577A (en) * 1981-11-16 1985-01-01 The Medical College Of Ohio Antagonists of the antidiuretic action of arginine vasopressin

Also Published As

Publication number Publication date
WO1995000548A1 (en) 1995-01-05
CZ332295A3 (en) 1996-06-12
US5698516A (en) 1997-12-16
SE501677C2 (sv) 1995-04-10
HU9503596D0 (en) 1996-02-28
FI956050L (fi) 1995-12-15
KR960702847A (ko) 1996-05-23
CA2163352A1 (en) 1995-01-05
NO955058D0 (no) 1995-12-13
HUT73674A (en) 1996-09-30
NO955058L (no) 1995-12-13
FI956050A7 (fi) 1995-12-15
EP0703924A1 (en) 1996-04-03
AU7088394A (en) 1995-01-17
FI956050A0 (fi) 1995-12-15
CN1125451A (zh) 1996-06-26
SE9302124D0 (sv) 1993-06-18
JPH08511557A (ja) 1996-12-03
PL312202A1 (en) 1996-04-01
ZA944195B (en) 1995-02-08
SE9302124L (sv) 1994-12-19

Similar Documents

Publication Publication Date Title
PL298146A1 (en) Biologically active mixture
LT99052A (en) Heptapeptide oxytocin analogues
IL110018A0 (en) Biologically active vasopressin analogues
EP0644769A4 (en) BIOLOGICALLY ACTIVE PEPTIDES WITH N-TERMINAL SUBSTITUTIONS.
PL310007A1 (en) Insulin analogues
IL101587A0 (en) Biologically active peptide composition and uses therefor
ZA936692B (en) Physiologically active peptide composition
GB9210419D0 (en) Cathode structures
AU6156294A (en) Physiologically active peptide
AU6582694A (en) Biologically active peptides
HU9200678D0 (en) Peptide analogues
GB2284418B (en) Z-Benzylidene-Tetrahydroquinolines and analogues thereof
GB9315411D0 (en) Active agent delivery
GB9309565D0 (en) Biologically and therapeutically active agents
GB9308573D0 (en) Biologically and therapeutically active agents
GB9312668D0 (en) Pharmacologically active compounds
GB9310830D0 (en) Pharmacologically active compounds
GB9316531D0 (en) Pharmacologically active compounds
GB9319555D0 (en) Active electrode
GB9316508D0 (en) Biologically active molecules
GB9323344D0 (en) Pharmaceutically active compounds
GB9305661D0 (en) Pharmaceutically active compounds
GB9326512D0 (en) Pharmaceutically active compounds
GB9307741D0 (en) Pharmaceutically active compounds
GB9323345D0 (en) Pharmaceutically active compounds